Compumedics Limited
Compumedics Limited
- P/E ratio
- 218.18
Your view on CMP.AX
Overview
What the company does, where it operates, and who runs it.
About Compumedics Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- David Burton
- Headquarters
- 30-40 Flockhart Street, Abbotsford, VIC, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- David Burton
- Headquarters
- 30-40 Flockhart Street, Abbotsford, VIC, AU
Compumedics Limited is a global medical technology enterprise engaged in the full lifecycle of designing, producing, marketing, and distributing advanced diagnostic medical devices. Its market reach extends across Australia, the Asia Pacific region, the Americas, Europe, and the Middle East.
The company's product portfolio is primarily focused on solutions for sleep and neurological disorders.
For sleep diagnostics, offerings include sophisticated PSG:EEG amplification systems like the Grael 4K, portable recording units such as the Somté PSG and Siesta 802, wearable monitoring devices like Somfit/Somfit Pro, and transcutaneous monitors (e.g., TCM5 FLEX). In the field of neurology, Compumedics supplies devices like the ONsight A.V.S.
for home ambulatory studies, a variety of EEG amplifiers (e.g., Grael 4K-EEG, Grael LT EEG), comprehensive long-term EEG monitoring systems (Neuvo 64-512 Channel LTM), and specialized EMG/EP systems (including Xegis Forte and Xegis G:NEO).
Complementing its hardware, the company develops an extensive range of software, featuring the Profusion Sleep and EEG platforms, Profusion neXus 360 (a web-based system for patient data and lab management), a Multi-Modal Neuroimaging Suite, and workflow optimization tools like Profusion neXus Laboratory Management and Scheduler.
Other software offerings include HD Digital Video integration and various specialized applications.
Furthermore, Compumedics provides magnetoencephalography systems, cutting-edge brain research technologies, services for pharmaceutical clinical trials and research, as well as a diverse array of accessories and consumables crucial for diagnostic and research endeavors.
Established in 1987, Compumedics Limited is based in Abbotsford, Australia, and functions as a subsidiary of D & DJ Burton Holdings Pty Ltd.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Compumedics Limited. Starting points for Compumedics Limited: P/E 218.2, beta 0.37 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Compumedics Limited. Compumedics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Compumedics Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrJun 2017 | Next QtrJun 2022 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | AUD 0.01 | AUD 0.02 | AUD 0.02 | AUD 0.03 |
| Low estimate | AUD 0.01 | AUD 0.02 | AUD 0.02 | AUD 0.03 |
| High estimate | AUD 0.01 | AUD 0.02 | AUD 0.02 | AUD 0.03 |
| No. of analysts | 3 | 2 | 1 | 1 |
| Year-ago EPS | — | — | AUD 0.001 | — |
| Growth | — | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrJun 2017 | Next QtrJun 2022 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | AUD 38.86M | AUD 55.32M | AUD 75.60M | AUD 91.00M |
| Low estimate | AUD 31.82M | AUD 42.49M | AUD 75.60M | AUD 91.00M |
| High estimate | AUD 44.65M | AUD 66.50M | AUD 75.60M | AUD 91.00M |
| No. of analysts | 3 | 3 | 1 | 1 |
| Year-ago revenue | — | — | AUD 60.25M | — |
| Growth | — | — | +25.5% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Compumedics Limited. Compumedics Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ATX.AXAmplia Therapeutics Limited | Healthcare | Biotechnology | — | ||
| BMT.AXBeamtree Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| CSX.AXCleanSpace Holdings Limited | Healthcare | Medical - Devices | — | ||
| CYC.AXCyclopharm Limited | Healthcare | Medical - Devices | — | ||
| CYP.AXCynata Therapeutics Limited | Healthcare | Biotechnology | — | ||
| DOC.AXDoctor Care Anywhere Group PLC | Healthcare | Medical - Healthcare Information Services | — | ||
| GSS.AXGenetic Signatures Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IPD.AXImpediMed Limited | Healthcare | Medical - Devices | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBL.AXControl Bionics Limited | Healthcare | ASX | — | ||
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
| CLPTClearPoint Neuro, Inc. | Healthcare | NASDAQ | $247.1M | ||
| CLVSFCellaVision AB (publ) | Healthcare | OTC | $378.0M | ||
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
| CNVIFConavi Medical Corp. | Healthcare | OTC | $20.7M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Compumedics Limited. Coverage tracks Compumedics Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Compumedics Limited.